GlassScriptPhysician profile
Vallabh N Patel
NPI 1750344214
$22,881.45
in general payments reported to CMS, 2019-2025
48 companies · $3,386 in 2025
The $3,386 reported for 2025 was more than what 97% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,699 · 2020: $1,234 · 2021: $1,631 · 2022: $1,873 · 2023: $2,942 · 2024: $10K · 2025: $3,386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $3,043 · Education: $13.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,387.50 |
| Food and Beverage | $3,042.87 |
| Education | $13.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Csl Plasma INC. | $13,387.50 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $809.28 | 2019-2025 | Farxiga, Breztri, Lokelma |
| Janssen Pharmaceuticals, INC | $807.74 | 2019-2023 | Xarelto |
| Sanofi-Aventis U.S. LLC | $800.69 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $787.49 | 2019-2024 | Jardiance |
| Novo Nordisk INC | $695.66 | 2019-2024 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $540.67 | 2019-2024 | Arexvy, Trelegy Ellipta, Shingrix |
| Merck Sharp & Dohme LLC | $510.15 | 2019-2023 | Verquvo, Belsomra, Steglatro |
| Abbvie INC. | $432.15 | 2021-2024 | |
| Lilly USA, LLC | $399.53 | 2019-2024 | Mounjaro, Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $380.78 | 2019-2024 | Xifaxan |
| Bayer Healthcare Pharmaceuticals INC. | $339.23 | 2021-2024 | |
| Astellas Pharma US INC | $328.99 | 2019-2024 | Veozah, Myrbetriq |
| Amgen INC. | $255.76 | 2019-2023 | Evenity, Prolia, Otezla |
| Nestle Healthcare Nutrition INC. | $251.04 | 2021-2022 |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vallabh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.